Strategies for combination therapy in oncology: Part two – Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In...
Walter Colasante is a vice president in the Life Sciences Practice at CRA. He has experience in both the pharmaceutical and consulting industries. Walter has experience across a range of different therapeutic areas, most notably oncology, CNS, and rare diseases.
Prior to his role at CRA, Walter was a senior principal at a global life sciences company, consulting primarily in global market access strategies and EU parallel trade. In the pharmaceutical industry, he has held several clinical research positions. At a pharmaceutical corporation, he was International Brand Director for its retinal products franchise. He is fluent in Italian and French.